Skip to main content
Year archive

Kamada Ltd. — 2021 filings

All 45 regulatory filings released by Kamada Ltd. (KMDA) in 2021, sourced directly from the official regulator.

45 Filings
2021 Period
2021 filings (45)
Filing Released Lang
Results of the 2021 Annual General Meeting of Shareholders held on December 16, 2021
AGM Information
2021-12-16 English
Results of the 2021 Annual General Meeting of Shareholders held on December 16, 2021
AGM Information
2021-12-16 English
Kamada Announces Strategic Transformational Transaction Positioning the Company as a Global Leader in the Plasma-Derived Hyperimmune Market Through the Acquisition of a Portfolio of Four FDA-Approve
Regulatory Filings
2021-11-22 English
Kamada Announces Strategic Transformational Transaction Positioning the Company as a Global Leader in the Plasma-Derived Hyperimmune Market Through the Acquisition of a Portfolio of Four FDA-Approve
Report Publication Announcement
2021-11-22 English
Kamada Reports Third Quarter and First Nine Months of 2021 Financial Results, and Strategic Transformational Acquisition of a Portfolio of Four FDA-Approved Plasma-Derived Hyperimmune Commercial Prod
Earnings Release 9M 2021
2021-11-22 English
Kamada Reports Third Quarter and First Nine Months of 2021 Financial Results, and Strategic Transformational Acquisition of a Portfolio of Four FDA-Approved Plasma-Derived Hyperimmune Commercial Prod
Report Publication Announcement 9M 2021
2021-11-22 English
Kamada to Announce Third Quarter Financial Results and Host Conference Call on November 22, 2021
Earnings Release 9M 2021
2021-11-08 English
Kamada to Announce Third Quarter Financial Results and Host Conference Call on November 22, 2021
Report Publication Announcement
2021-11-08 English
NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS
AGM Information
2021-11-04 English
NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS
Proxy Solicitation & Information Statement
2021-11-04 English
NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS
AGM Information
2021-11-04 English
Annual General Meeting to be held on December 16, 2021
AGM Information
2021-11-04 English
Annual General Meeting to be held on December 16, 2021
AGM Information
2021-11-04 English
Reports Second Quarter and First Half 2021 Financial Results
Interim / Quarterly Report H1 2021
2021-08-11 English
Reports Second Quarter and First Half 2021 Financial Results
Report Publication Announcement
2021-08-11 English
Kamada to Announce Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 11, 2021
Earnings Release H1 2021
2021-08-05 English
Kamada to Announce Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 11, 2021
Report Publication Announcement
2021-08-05 English
FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children”
Regulatory Filings
2021-06-02 English
FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children”
Report Publication Announcement
2021-06-02 English
Kamada Reports First Quarter 2021 Financial Results
Interim / Quarterly Report Q1 2021
2021-05-12 English
Kamada Reports First Quarter 2021 Financial Results
Report Publication Announcement
2021-05-12 English
Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2021
Regulatory Filings
2021-05-05 English
Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2021
Report Publication Announcement
2021-05-05 English
Announces Amendment to GLASSIA® License Agreement with Takeda
Regulatory Filings
2021-04-07 English
Announces Amendment to GLASSIA® License Agreement with Takeda
Report Publication Announcement
2021-04-07 English
Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globulin (IgG) Treatment for Coronavirus Disease (COVID-19)
Regulatory Filings
2021-03-31 English
Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globulin (IgG) Treatment for Coronavirus Disease (COVID-19)
Report Publication Announcement
2021-03-31 English
Present at the Jefferies Global Plasma Summit
Investor Presentation
2021-03-09 English
Present at the Jefferies Global Plasma Summit
Regulatory Filings
2021-03-09 English
Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.
Regulatory Filings
2021-03-03 English
Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in the U.S.
Report Publication Announcement
2021-03-03 English
Form 20F_Annual Report for the Year Ended December 31, 2020
Annual Report FY 2020
2021-02-24 English
Form 20F_Annual Report for the Year Ended December 31, 2020
Report Publication Announcement FY 2020
2021-02-24 English
Kamada Files Annual Report for the Year Ended December 31, 2020
Report Publication Announcement
2021-02-24 English
Kamada Files Annual Report for the Year Ended December 31, 2020
Report Publication Announcement FY 2020
2021-02-24 English
Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
Earnings Release Q4 2020
2021-02-10 English
Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
Report Publication Announcement
2021-02-10 English
Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021
Regulatory Filings
2021-02-03 English
Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021
Report Publication Announcement
2021-02-03 English
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
Regulatory Filings
2021-02-01 English
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
Report Publication Announcement
2021-02-01 English
Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel
Regulatory Filings
2021-01-13 English
Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel
Report Publication Announcement
2021-01-13 English
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition; Award Recognizes Israeli Companies Working to Combat Coronavirus and the Damage of Future Pandemic
Regulatory Filings
2021-01-05 English
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition; Award Recognizes Israeli Companies Working to Combat Coronavirus and the Damage of Future Pandemic
Report Publication Announcement
2021-01-05 English